WHO ICTRP trial

A study comparing two groups of drug combination for better outcome for…

CTRI/2023/07/054860 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2023/07/054860
Public title A study comparing two groups of drug combination for better outcome for intubation in cancer patients.
Scientific title A study to compare the efficacy of combination regimen of dexmedetomidine and midazolam versus ketofol (ketaminetpropofol) for sedation in awake fiberoptic intubation (AFO) in head and neck cancer patients-a randomized clinical trial.
Primary sponsor Department of Onco- Anaesthesia and Palliative Medicine AIIMS New Delhi
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: O- Medical and Surgical
Interventions Intervention1: DEXMEDETOMIDINE AND MIDAZOLAM: Inj Midazolam 0.02mg/kg + Inj Dexmedetomidine infusion at 1mcg/kg over 10 mins f/b 0.5mcg/kg/hour Control Intervention1: KETAMINE AND PROPOFOL: Inj Ketofol in 2:1 ratio at 0.125 mL/kg over 10…
Registration date Jun 7, 2023
Target size 140
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations